Inventor
SHELEKHIN TATIANA
US18 patents
⚠️ This page may combine multiple inventors who share the name “SHELEKHIN TATIANA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
7 patentsUS10208052B1Feb 19, 2019
Compositions for activating pyruvate kinase
FORMA THERAPEUTICS INC36 citations97
US10472371B2Nov 12, 2019
Compositions for activating pyruvate kinase
FORMA THERAPEUTICS INC13 citations92
US11649242B2May 16, 2023
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
FORMA THERAPEUTICS INC5 citations85
US11396513B2Jul 26, 2022
Compositions for activating pyruvate kinase
FORMA THERAPEUTICS INC6 citations85
US11014927B2May 25, 2021
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
FORMA THERAPEUTICS INC6 citations84
US10836771B2Nov 17, 2020
Compositions for activating pyruvate kinase
FORMA THERAPEUTICS INC7 citations84
US10913753B2Feb 9, 2021
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
FORMA THERAPEUTICS INC2 citations61
NOVO NORDISK HEALTHCARE AG
4 patentsUS11980611B2May 14, 2024
Treating sickle cell disease with a pyruvate kinase R activating compound
NOVO NORDISK HEALTHCARE AG3 citations85
US12122778B2Oct 22, 2024
Activating pyruvate kinase R
NOVO NORDISK HEALTHCARE AG0 citations62
US12071440B2Aug 27, 2024
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
NOVO NORDISK HEALTHCARE AG0 citations62
US12053458B2Aug 6, 2024
Treating sickle cell disease with a pyruvate kinase R activating compound
NOVO NORDISK HEALTHCARE AG0 citations62
VALO EARLY DISCOVERY INC
3 patentsUS11524966B1Dec 13, 2022
Carboxamides as ubiquitin-specific protease inhibitors
VALO EARLY DISCOVERY INC2 citations72
US10889592B2Jan 12, 2021
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
VALO EARLY DISCOVERY INC2 citations71
US12162888B2Dec 10, 2024
Carboxamides as ubiquitin-specific protease inhibitors
VALO EARLY DISCOVERY INC0 citations51